JOHNS HOPKINS EXPERTS PUBLISH GUIDEBOOK FOR BLOOD PLASMA THERAPY
A team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centers rapidly scale up their ability to deliver so-called convalescent plasma therapy, which leverages immune system components found...
AI tailors artificial DNA for future drug development
With the help of artificial intelligence, Swedish researchers have succeeded in designing synthetic DNA that controls the cells’ protein production.
The technology, developed at Chalmers University of Technology, can contribute to the development and production...
The benefits of government apprenticeship reforms to employers
Apprenticeships offer employers large and small a fantastic opportunity to get the skilled workforce they need to grow their business.
There are hundreds of thousands of employers up and down the country that are already...
How different funding models are driving research towards commercialisation
Taking innovation forward can be a complex process, and university commercialisation offices help academics with specialist support to bring their research to market.
UCL Business (UCLB) is a leading commercialisation office and a part of...
Researchers are making great strides
We have made great strides in the fight against heart disease over the past 50 years. Since 1961, when the British Heart Foundation was established, the annual number of deaths from CVD in the...
Bolder Faster Stronger, how far can we go in the battle against illness?
Earlier this year, Austrian researchers came up with the startling suggestion that life should be regarded as beginning at sixty five.
Researchers at the International Institute for Applied Systems Analysis examined predicted ageing rates up...
DEPArray™ Technology unleashesthe power of NGS
Next-Generation Sequencing (NGS) has the potential to revolutionize clinical oncology by providing direct, actionable molecular information about tumor cells. Such information could be used to stratify patients for appropriate clinical trials assignment, select of...
Organ functions of the human yolk sac revealed
The role of the human yolk sac in supporting early embryonic development and the first wave of the prenatal immune system has been mapped in a study published in Science.
Researchers from the Wellcome Sanger...
Breakthrough access to epigenome and streamlines workflows
In an industry first, biotech pioneers PacBio announce significant enhancements to the Sequel II/IIe platform include methylation calling in native DNA, greatly accelerated sample preparation, and support for gene therapy applications.
Californian-based Pacific Biosciences (PacBio)...
‘Avatar’ motion tech aids advances in disease research
AI and motion capture technology are helping track the progression of rare genetic diseases affecting movement - and could ultimately be used to monitor common medical conditions like strokes.
In two ground-breaking studies, published in...
The promise of immuno-oncology: An R&D perspective
Dr Robin Knight, CEO and co-founder, IN-PART, discusses emerging cancer immunotherapies.
Cancer immunotherapy, also referred to as immuno-oncology, is gaining traction. New treatments are becoming available all the time, and they’re showing incredible promise in...
Why are obesity rates increasing?
I know what’s been causing obesity rates to rise. So do you. So does just about everyone. Unfortunately, most of us are probably wrong.
As I tell my students, correlation doesn’t prove causation, but that’s...
Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms
A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time.
A UCL-led team of international scientists have built on...
Everyday tablet could lead to relief for cancer sufferers
Another example of immunology at work is new research that suggests that giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment.
Francis Crick Institute researchers, funded...
Replace FBS with Human Platelet Lysate
The manufacture of clinical-grade cellular products often requires ex vivo culture and expansion of human cells.
Fetal bovine serum (FBS) is frequently used as a supplement to basal cell culture media during expansion; however, its...
Regulatory compliance is the top supply chain concern for healthcare companies globally
Complying with ever-changing regulations continues to be the top concern for healthcare executives, according to the 2014 UPS Pain in the (Supply) Chain survey.
Six out of ten executives mentioned regulatory compliance as their...